Kataoka Fumiya, Inoue Dai, Watanabe Masato, Fukuda Keita, Nobusawa Tsubasa, Umemura Kayo, Miura Natsuki, Yokota Takuya, Yoshioka Astushi, Shimoji Kohei, Nakazono Ayano, Horike Hideyuki, Ogura Yuki, Hayashi Tatsuya, Morita Yasuhiro, Namiki Shin
Department of Gastroenterology Tokyo Metropolitan Tama Medical Center Tokyo Japan.
Department of Digestive Surgery Tokyo Metropolitan Tama Medical Center Tokyo Japan.
DEN Open. 2021 Sep 8;2(1):e55. doi: 10.1002/deo2.55. eCollection 2022 Apr.
Plastic stents (PS) used for preoperative biliary drainage (PBD) of pancreatic ductal adenocarcinomas (PDAC) tend to be associated with a high incidence of recurrent biliary obstruction (RBO). Although 10-mm diameter fully covered self-expanding metallic stents (FCSEMS) have come into use, vigilance is still required to prevent complications, such as cholecystitis and surgical site infection. The present study examined the efficacy and safety of the 6-mm diameter FCSEMS for PBD.
The present retrospective study compared the incidence of complications associated with the use of 6-mm FCSEMS and PS. The inclusion criteria were a diagnosis of PDAC and preoperative endoscopic biliary tract drainage performed at our institution between April 2012 and June 2019.
Of the 51 patients enrolled, 25 and 26 patients received a PS and a 6-mm FCSEMS, respectively. The RBO incidence was significantly lower in the 6-mm FCSEMS group (7.7%) than in the PS group (40.0%) ( = 0.009), and time to RBO was significantly longer in the 6-mm FCSEMS group (HR = 6.008, = 0.021). The patency rate at three months after stent placement was significantly higher in the latter group (83.5% vs. 45.3%, = 0.009, Log-rank test). The groups did not differ significantly in terms of complications associated with PBD, such as cholecystitis and surgical site infection.
The present findings suggested that the 6-mm FCSEMS may be an effective drainage device for use in PBD in PDAC treatment.
用于胰腺导管腺癌(PDAC)术前胆道引流(PBD)的塑料支架(PS)往往与复发性胆道梗阻(RBO)的高发生率相关。尽管直径10毫米的全覆膜自膨式金属支架(FCSEMS)已开始使用,但仍需警惕预防胆囊炎和手术部位感染等并发症。本研究探讨了直径6毫米的FCSEMS用于PBD的有效性和安全性。
本回顾性研究比较了使用直径6毫米FCSEMS和PS相关并发症的发生率。纳入标准为2012年4月至2019年6月在本机构诊断为PDAC并接受术前内镜胆道引流的患者。
在纳入的51例患者中,分别有25例和26例患者接受了PS和直径6毫米的FCSEMS。直径6毫米FCSEMS组的RBO发生率(7.7%)显著低于PS组(40.0%)(P = 0.009),直径6毫米FCSEMS组的RBO发生时间显著更长(HR = 6.008,P = 0.021)。支架置入后三个月的通畅率在后一组中显著更高(83.5%对45.3%,P = 0.009,对数秩检验)。两组在与PBD相关的并发症如胆囊炎和手术部位感染方面无显著差异。
本研究结果表明,直径6毫米的FCSEMS可能是PDAC治疗中用于PBD的一种有效引流装置。